Stephane Bancel’s warning was issued when the G7 Health Minister held an emergency consultation on a new variety, which spread around the world and urged countries to close their borders again or impose a new travel ban. rice field.
Healthcare professionals will fill their syringes with the Moderna COVID-19 vaccine on December 24, 2020 at the East Boston Neighborhood Health Center in Boston, Massachusetts, USA. Photo: AFP.
Hong Kong-The existing COVID-19 jab will be fighting the Omicron variant, and it will take months to develop a new shot that works, said the head of U.S. vaccine maker Moderna: increase.Financial Times..
Scientists weren’t optimistic, although Stephane Bancel told the newspaper in an interview released Tuesday that data on the efficacy of the current vaccine would be available in the next two weeks.
“All the scientists I talked to … are like” this wouldn’t be good “,” he told the newspaper.
Bansel’s warning was issued when the G7 Health Minister held an emergency consultation on a new variety, which spread around the world and urged countries to close their borders again or impose a new travel ban.
The World Health Organization calls the risk of Omicron “very high.”
Researchers are concerned that 32 of the 50 mutations found in the Omicron variant were in pesplomers, which are part of the virus that the vaccine uses to strengthen the immune system against COVID, Bansel said. He said he was.
He said FT There is a “material decline” in the current effectiveness of jabs on omicron.
Moderna has already stated that it is working on Omicron-specific vaccines, similar to US pharmaceutical company Pfizer.
CEO Vansel said his company could deliver doses of 2 to 3 billion in 2022, but would move all production to Omicron-specific shots while other virus strains are still in circulation. Said it was dangerous.
His more disturbing tone contrasts with politicians’ efforts to project calm with respect to Omicron.
US President Joe Biden said on Monday that the tension was “not the cause of the panic.”
Moderna bosses say vaccines are unlikely to be comparable to Omicron: FT
Source link Moderna bosses say vaccines are unlikely to be comparable to Omicron: FT